LIFECORE BIOMEDICAL, INC. Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent
LIFECORE BIOMEDICAL, INC. (LFCR) had Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent of $0 as of 2023-05-28, per its 10-K filed 2024-03-20.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent · last filed 2024-03-20
- 2023-05-28: Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent $0.00.
- 2023-02-26: Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent $518.00K; Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent as first filed $0.00.
- 2022-11-27: Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent $1.98M.
- 2022-08-28: Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent $2.15M.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent | Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent as first filed |
|---|---|---|
| 2023-05-28 | $0.00 10-K · filed 2024-03-20 | |
| 2023-02-26 | $518.00K 10-K · filed 2024-03-20 | $0.00 10-Q · filed 2023-06-02 |
| 2022-11-27 | $1.98M 10-K · filed 2024-03-20 | |
| 2022-08-28 | $2.15M 10-K · filed 2024-03-20 | |
| 2022-05-29 | $2.33M 10-K · filed 2024-03-20 | $0.00 10-K · filed 2022-09-14 |
| 2022-02-27 | $2.49M 10-K · filed 2024-03-20 | $0.00 10-Q · filed 2022-04-07 |
| 2021-11-28 | $4.82M 10-K · filed 2024-03-20 | |
| 2021-08-29 | $6.15M 10-K · filed 2024-03-20 | |
| 2021-05-30 | $6.96M 10-K · filed 2024-03-20 | $14.76M 10-Q · filed 2022-04-07 |
| 2021-02-28 | $7.24M 10-K · filed 2024-03-20 | |
| 2020-11-29 | $8.06M 10-K · filed 2024-03-20 | |
| 2020-08-30 | $7.86M 10-K · filed 2024-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |